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The effect of viable Chlamydia pneumoniae on serum cyto- of intercellular signaling peptides, such as cytokines, ad-
kines and adhesion molecules in hemodialysis patients. hesion molecules, and growth factors, produced by acti-
Background. Chlamydia pneumoniae (Cp) induces the pro- vated cells are among the main effector molecules in-duction of cytokines and adhesion molecules in infected host
volved in this process [1]. Chlamydia pneumoniae (Cp)eukaryotic cells. The causes for pro-inflammatory cytokine and
adhesion molecule increase in hemodialysis (HD) patients have is the microorganism most frequently implicated in the
not been fully elucidated. The possibility that, in this particu- infection-based inflammatory atherogenous hypothesis
larly atherosclerotic population, Cp, a microorganism impli- [2]. A continuously increasing amount of mainly experi-
cated in the infectious-based inflammatory hypothesis of ath-
mental work shows that Cp is capable of infecting anderosclerosis’ is also responsible for these molecules’ increase
activating all types of cells involved in atheroma forma-is assessed in this study.
Methods. In 130 stable HD patients, serum interleukin-1 tion and development [3].
(IL-1), interleukin-6, tumor necrosis factor , interleukin-10, On the other hand, hemodialysis (HD) patients are in
L-selectin, E-selectin, intercellular adhesion molecule-1, and an inflammatory state and the cytokine-adhesion mole-vascular cell adhesion molecule-1 (VCAM-1) levels were deter-
cules network is disturbed [4]. The causes for this distur-mined. Cp presence was identified by inoculation of the pa-
tient’s peripheral blood mononuclear cells (PBMCs) in Hep-2 bance are not fully understood. Chronic persistent infec-
cell lines and subsequent polymerase chain reaction (PCR) in tions may be a cause for these molecules’ increases [4]
DNA extracted from cell cultures, as well as by determination and Cp might be associated with inflammation in these
of serum IgG antibodies against Cp (IgGCp).
patients [5, 6].Results. Patients, positive or negative for IgGCp, had no
The aim of this study was to correlate Cp presencestatistically significant differences in all molecules measured.
Patients with viable Cp in PBMCs had higher serum levels of with a series of pro-inflammatory cytokines, the anti-
IL-1 and soluble VCAM-1 than negative ones for IgGCp (IL-1 inflammatory interleukin 10 (IL-10), and soluble adhe-
6.87  7.35 vs. 2.34  1.47 pg/mL; P  0.0009 and VCAM-1 sion molecules determined in serum of HD patients, in1647.16  513.64 vs. 1162.14  546.83 ng/mL; P  0.0115,
an effort to explore the possibility that chronic persistentrespectively). Viable Cp in PBMCs remained a significant pre-
infection with Cp is a cause for these disturbances in thisdictor factor for IL-1 and VCAM-1 in statistical analysis, when
patients’ characteristics and dialysis conditions were also evalu- particularly atherosclerotic category of patients.
ated.
Conclusions. Our results showed that some serum cytokine
and adhesion molecule increase in HD patients could be attrib- METHODS
uted to viable Cp presence in PBMCs. These findings support
One hundred forty-two stable HD patients were exam-the Cp-based inflammatory atherogenous hypothesis and add a
better understanding of these molecules’ increase in HD patients. ined after informed consent was given. Twelve patients
were excluded because of active infection the month
before study initiation. Forty percent of the remaining
Inflammation plays a central role in the initiation and 130 subjects were females; 61.91  13.72 (mean  SD)
progression of atherosclerosis [1]. A complex network (range, 18 to 87 years) years old, 23.4% were smokers,
14.6% were diabetics, 44.6% were hypertensives, 18.2%
had chronic bronchitis, 32.3% were on angiotensin-con-Key words: cell cultures, PCR, peripheral blood mononuclear cells,
IL-1, VCAM-1, IL-10, selectins. verting enzyme inhibitors, 37% were on acetylsalicylic
acid (80 mg/day), and 1.2% were on statins. Body mass 2003 by the International Society of Nephrology
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index was 25.72  4.49 and serum albumin 4.05  0.28 Preparation of buffy coats. Five mL of EDTA-whole
blood from each patient was centrifuged at 3000 g forg/dL. The cause of end-stage renal failure was chronic
glomerulonephritis for 40% of patients, hypertensive 15 minutes. The buffy coat was carefully aspirated with
a sterile Pasteur pipette, transferred into 2.5 mL cryo-nephrosclerosis for 16.9% of patients, polycystic disease
for 14.6% of patients, diabetic nephropathy for 10.8% vials, and stored at 160C of liquid nitrogen until the
day of determination.of patients, other causes for 7.7% of patients, and the
cause was unknown in 10% of patients. The time in HD Cell cultures. Cell cultures were performed by the shell
vial technique using a commercially available kit (Vircell,was 72.77  65.07 (1 to 280) months; 88.5% had an
A-V fistula; 39.2% had nonfunctioning vascular accesses; S.L., Granada, Spain). Cells were detached after shaking
with glass beads, and the resulting homogenates were96.9% were on classic HD with bicarbonates; 3.1% on
hemodiafiltration; 68.3% were dialyzed with a modified used for the PCR detection of Cp. Controls consisted
of C. pneumoniae ATCC VR-1355 TWAR strain 2043cellulose membrane, and 36.2% were dialyzed with a
synthetic one. The dialyzer ultrafiltration coefficient was suspensions, which were run as the buffy coat samples.
PCR for Cp. For the detection of Cp in cell culture10 mL/hour mm Hg in 66.2% of patients, the dialysis
filter surface area 1.65  0.30 m2, and the water pro- homogenates, a nested PCR was performed using a com-
mercially available kit (Clonit srl, Milano, Italy). Thecessing was common for the whole group of patients.
amplification product was a 193 base pair (bp) fragment
Blood collection of the gene encoding the RNA polymerase beta of Cp.
Amplified products were detected by conventional aga-Blood samples of 15 mL were taken before dialysis from
vascular access immediately following venipuncture within rose-gel electrophoresis. Extraction procedures of DNA
from cell culture homogenates were included in the kit.two consecutive days for all patients. Two 5 mL EDTA
tubes were used for the cell cultures, and one 5 mL tube The above PCR protocol succeeded in detecting about
20 to 30 C. pneumoniae elementary bodies in 300 mL ofwithout anticoagulant was used for cytokines, adhesion
molecules, and serum IgG antibodies against Cp (IgGCp) cell culture medium, as confirmed after staining of air-
dried suspensions with anti-Cp fluorescent monoclonaldetermination.
antibody. This was a very good sensitivity, as compared
Serum cytokines and soluble adhesion molecule assays with previous reports [7]. In the specificity control, PCR
failed to detect DNA from a mixed suspension of ATCCSera separated from the coagulated blood by centrifu-
gation within 30 minutes after collection were trans- reference strains, including Esherichia coli, Staphylococ-
cus aureus, Pseudomonas aeruginosa, Haemophilus in-ferred immediately to sterile tubes and stored at 20C
until use. Interleukin 1 (IL-1) (intra-assay/interassay fluenzae, Enterococcus faecalis, Candida albicans, and
Campylobacter jejuni.precision 8.5%/8.4%), interleukin-6 (IL-6) (4.3%/6.3%),
tumor necrosis factor  (TNF) (5.2%/7.4%), IL-10 (5%/
Statistics7.3%), L-selectin (L-sel) (6.8%/9.9%), E-selectin (E-sel)
(5%/8.8%), soluble intercellular adhesion molecule-1 All molecules determined and used in our analysis
with parametric techniques were transformed to their(ICAM-1) (4.8%/7.4%), and soluble vascular cell adhe-
sion molecule-1 (VCAM-1) (5.9%/10.2%) were evalu- natural logarithms due to their highly skewed distribu-
tion. Results are expressed as mean  SD of the initialated by enzyme-linked immunosorbent assay (ELISA)
(R&D System Europe, Ltd., Oxon, United Kingdom). values. Spearman’s correlation coefficient was calculated
for the univariate analysis between initial values of theAll samples and standards were assayed in duplicate.
parameters. Multivariate one way analysis of variance
IgGCp assay (MANOVA) was initially used to compare the vectors
of means of eight molcules (IL-1, IL-6, TNF, IL-10, E-sel,Sera separated from blood samples were aseptically
transferred to sterile tubes and stored at 20C until L-sel, ICAM-1, and VCAM-1), determined between the
patients with or without viable Cp in PBMCs, as well asuse. IgGCp were determined by indirect micro-immuno-
fluorescent assay (MIF) techniques (MRL Diagnostics, between patients with IgGCp titer1/32 and1/32. The
results (data not shown) strongly suggested that one orCypress, CA, USA). The serum screening dilution was
1/16 in phosphate buffered saline (PBS). End point titers more of the means were different between the two for-
mer groups, but not between the latter two. After the1/16 were considered positive, providing evidence of
infection at an undetermined time. multivariate analysis, the univariate t test was applied in
order to determine which one of the means differed
Detection of viable Cp in PBMCs between various groups of patients. Multiple linear re-
gression analysis was applied as described in the ResultsCp was isolated from PBMCs after inoculation of
Hep-2 cell cultures with buffy coats and subsequent de- section. A significance level of 0.05 was used for all sta-
tistical tests.tection by PCR.
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Table 1. Serum cytokine and soluble adhesion molecules in patients with or without Chlamydia pneumoniae in Peripheral Blood Mononuclear
Cells and serum IgG Cp antibodies 1/32 or 1/32
Cp in PBMCsa IgGCpb
Positive Negative 1/32 1/32
(9 patients) (121 patients) P value (37 patients) (93 patients) P value
IL-1c pg/mL 6.877.35 2.341.47 0.0009k 2.621.57 2.672.91 0.8529
IL-6d pg/mL 7.805.11 8.9812.49 0.7434 7.757.46 9.3513.52 0.8231
TNFe pg/mL 11.483.70 14.1116.22 0.9991 14.0820.16 13.8723.63 0.3098
IL-10f pg/mL 6.458.21 4.617.21 0.7241 4.134.16 4.988.19 0.6125
L-Selg ng/mL 1185.22227.15 1199410.12 0.6382 1162.28450.63 1212.35572.30 0.3766
E-Selh ng/mL 63.3322.76 76.7232.35 0.2725 74.6827.09 76.2333.74 0.9279
ICAM1i ng/mL 572.27180.01 612.19161.61 0.9373 601.11134.68 612.74172.90 0.8979
VCAM1j ng/mL 1647.16513.64 1162.14546.83 0.0115k 1093.12443.29 1120.50514.73 0.2999
a Chlamydia pneumoniae in PBMCs
b IgG serum antibodies against Chlamydia pneumoniae
c Interleukin 1
d Interleukin 6
e Tumor necrosis factor 
f Interleukin 10
g L-selectin
h E-selectin
i Intercellular adhesion molecule-1
j Vascular-cell adhesion molecule-1
k P  0.05; Student’s t-test was performed using natural logarithms for all molecules determined
RESULTS were significant predictors for the IL-1 serum level. With
the same statistical method and the natural logarithm ofSerum cytokines and soluble adhesion molecule levels
VCAM-1 as dependent factor, the predictors for thisfor the 130 HD patients were: IL-1, 2.66  2.59 pg/mL;
soluble adhesion molecule serum level were Cp inIL-6, 8.90  12.11 pg/mL; TNF, 13.93  15.68 pg/mL;
PBMCs (  0.4419, t  2.979, P  0.003) and ICAM-1IL-10, 4.74 7.26 pg/mL; L-sel 1198.22 399.60 ng/mL;
(  0.006, t  2.597, P  0.011).E-sel, 75.79  31.89 ng/mL; ICAM-1, 609.43  162.51
ng/mL; and VCAM-1, 1195 556.59 ng/mL. Statistically
significant correlations were found between L-sel and DISCUSSION
E-sel (r  0.2799, P  0.013), L-sel and ICAM-1 (r  In the present study we found that the few HD patients
0.2289, P  0.0089), E-sel and ICAM-1 (r  0.2682, P  with Cp in PBMCs had higher levels of serum IL-1 and
0.001), ICAM-1 and VCAM-1 (r  0.2410, P  0.0057), VCAM-1 than those without the presence of viable mi-
and a positive correlation was found between IL-6 and croorganism. Patients positive or negative for serum IgG
TNF (r  0.1613, P  0.0689). IL-10 was negatively, but antibodies against Cp did not have significantly different
not significantly, correlated with IL-1 and L-sel. serum cytokine or adhesion molecule levels.
Only 9 (6.9%) out of 130 patients were positive for Cp is capable of inducing the production of all mole-
viable Cp in PBMCs, while 64 patients (49.2%) were cules examined in this study from different cell types [2].
seropositive (titer 1/16), and 37 patients (28.3%) had Viable Cp presence in PBMCs, as was demonstrated by
a serum IgGCp titer 1/32. cell culture and PCR for the first time in this study, in-
Serum cytokines and soluble adhesion molecule levels creases the probability of cellular activation and produc-
in these patients are shown in Table 1. IL-1 and VCAM-1 tion of cytokines and adhesion molecules determined.
were significantly higher in patients positive for viable Why is it that only IL-1 and VCAM-1 were higher in
Cp in PBMCs than in those who were negative, but not patients positive for Cp compared to negative ones, while
in patients with IgGCp (titer 1/32) in comparison to the rest of molecules examined were not? The possible
those without serum IgGCp. explications are: (1) other cytokines or adhesion mole-
In stepwise multiple linear regression analysis, using cules genes are induced (IL-1 among them) in the in-
the natural logarithm of IL-1 as the dependent variable fected host cells by this pathogen and others are not [8];
and the positivity or negativity for viable Cp in PBMCs (2) the quantities of cytokines released by Cp infected
as independents, serum IgGCp 1/32 or 1/32, the rest cells are not the same [9]; (3) the infection of PBMCs
of cytokines and adhesion molecules, as well as all patient may have taken place at different times for each patient,
characteristics and dialysis conditions, with entry factors noting that a time- dependent secretion of cytokines
at P  0.05, and removing those factors no longer con- after Cp infection has been described [10]; and (4) host
tributing at P 	 0.10, only the viable Cp presence in cell polymorphisms of genes encoding cytokines and ad-
PBMCs (  0.9063, t  3.809, P  10–4) and the use hesion molecules [11] may influence the final production
of these molecules.of synthetic membrane ( 0.3651, t 2.840, P 0.005)
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VCAM-1 was significantly increased in patients posi- tributes to the cytokine and adhesion molecule distur-
bances in HD patients opens the discussion of possibletive for viable Cp than in those without Cp in PBMCs.
new causes needing further investigation, such as chronicThis finding may be of importance to the hypothesis link-
persistent infections, responsible for cellular activationing Cp to the atherosclerotic process because VCAM-1
and release of these molecules in this category of patients.is not expressed under baseline conditions, but is rapidly
induced by proatherosclerotic factors [12], as well as by
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